CGRP as the target of new migraine therapies - successful translation from bench to clinic.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- CGRP as the target of new migraine therapies - successful translation from bench to clinic.
- Published In:
- Nature reviews. Neurology, 14(6), 338-350 (2018)
- Authors:
- Edvinsson, Lars(6), Haanes, Kristian Agmund, Warfvinge, Karin(2), Krause, Diana N
- Database ID:
- RPEP-03657
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03657APA
Edvinsson, Lars; Haanes, Kristian Agmund; Warfvinge, Karin; Krause, Diana N. (2018). CGRP as the target of new migraine therapies - successful translation from bench to clinic.. Nature reviews. Neurology, 14(6), 338-350. https://doi.org/10.1038/s41582-018-0003-1
MLA
Edvinsson, Lars, et al. "CGRP as the target of new migraine therapies - successful translation from bench to clinic.." Nature reviews. Neurology, 2018. https://doi.org/10.1038/s41582-018-0003-1
RethinkPeptides
RethinkPeptides Research Database. "CGRP as the target of new migraine therapies - successful tr..." RPEP-03657. Retrieved from https://rethinkpeptides.com/research/edvinsson-2018-cgrp-as-the-target
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.